Doctor-led GLP-1 programs for women, opening soon. Join the founding list for first access in your state.
Get early access See treatmentsWhen we open, you answer a private medical intake. A clinician licensed in your state decides what is right for you, then stays with you.
One concierge team and one calm plan, from your first message to every refill.
Find my treatmentCare for the woman you already are, from providers who have time to listen.
Dispensed by licensed U.S. pharmacies, only after your provider writes the prescription.
Compounded semaglutide, taken once a week. Your provider starts low and steps up slowly. From $179/mo
Compounded tirzepatide, a dual GLP-1 and GIP option, taken once a week. From $299/mo
A single-dose pen format where your provider and pharmacy offer it. No drawing up doses. From $249/mo
A daily compounded tablet for women who would rather skip the needle. From $149/mo
Shown for illustration. Prescription only. Prices are expected launch pricing. A licensed provider decides whether treatment is right for you. Compounded medications are not FDA-approved.
GLP-1 injections and pens, prescribed and adjusted by a provider who checks in as you go.
The same medicine family in a daily tablet, with honest guidance on how it compares.
When we open: four steps, one care team, and a provider who knows your name.
Answer a private medical intake online. It takes about ten minutes and you can pause any time.
Your answers stay private.
A clinician licensed in your state reviews your answers, messages you directly and decides whether a prescription is right for you.
If prescribed, a licensed U.S. pharmacy prepares your medication and ships it discreetly, cold-packed where needed.
Dispensed by a licensed pharmacy
Regular check-ins, dose adjustments and unlimited messaging with your care team for as long as you are a member.
BMI is one of the first things a provider looks at when considering GLP-1 care. It is a starting point for the conversation, never a verdict on you.
Get early access to weight careA quick screening number that providers look at alongside your health history.
These results come from large clinical trials of FDA-approved branded medications. They are not SlimBelle. patient outcomes, and compounded versions were not studied in these trials.
Average body-weight reduction at 72 weeks on the highest tirzepatide dose, versus 3.1% on placebo, alongside diet and activity changes. SURMOUNT-1, NEJM 2022.
Average body-weight reduction at 68 weeks on weekly semaglutide 2.4 mg, versus 2.4% on placebo. STEP 1, NEJM 2021.
Lower risk of major cardiovascular events with semaglutide in adults with overweight or obesity and existing heart disease. SELECT, NEJM 2023.
Individual results vary. Common side effects include nausea, diarrhea and constipation. Your provider will talk through benefits and risks before prescribing.
Tap for sound.
Two minutes, no account needed. See which SlimBelle. program fits you, then join the founding list for first access when we open in your state.
Get early access
SlimBelle. opens soon. Join the founding list and we’ll email you when care opens in your state, with $25 off your first month of membership.
Applies to membership fees only, once we open. Unsubscribe any time.